Juvelook vs Rejuran: Which Fits Your Goals?

A balanced patient guide to Juvelook and Rejuran, including ingredient differences, safety checks, evidence boundaries and questions for a qualified consultation.

By Renz Medical Editorial Team

Skin boosters / A patient guide for Pakistan Juvelook vs Rejuran: which fits your goals? Two different formulations. A more useful comparison starts with what is in the product, what the evidence can tell you, and the questions to take to your doctor. What is the quick answer? Juvelook combines poly-D,L-lactic acid (PDLLA) with hyaluronic acid (HA), while the REJURAN injectable compared here contains polynucleotides (PN). The sources reviewed do not establish either as the better skin booster overall. The choice depends on your skin concern, the exact formulation, medical assessment and verified local supply. Ingredient references: Juvelook study and REJURAN manufacturer listing . Know which product is being compared. This guide covers standard Juvelook and the REJURAN PN injectable. It excludes Juvelook Volume, REJURAN i/s/HB plus and topical cosmetics. The separately named REJURAN Skin Booster has a different formula; the US Juvelook Skincare Serum is labelled for topical use. Never transfer an injectable claim to a topical product. [4] [5] 01 / PDLLA + HA Juvelook PDLLA is studied for collagen stimulation; HA is the accompanying water-binding material. A mechanism does not predict your result. [1] 02 / Polynucleotides REJURAN PharmaResearch identifies REJURAN as a salmon-derived PN medical device for temporary improvement of facial wrinkles. That claim is not proof of superiority. [3] Conceptual illustrations only. Shapes, locations and fibres are not anatomical measurements, treatment instructions or before-and-after outcomes. 01 / The comparison How do Juvelook and Rejuran compare? Ingredients differ; brand names alone do not settle suitability. The table separates sourced product information from clinic-specific details that still need checking. On a small screen, scroll sideways to compare both columns. What to compare : Juvelook : REJURAN PN injectable : Manufacturer / origin : VAIM Co., Ltd. / Republic of Korea. [1] [10] PharmaResearch Co., Ltd. / Republic of Korea. [2] [11] Composition / presentation : The cited study identifies 42.5 mg PDLLA + 7.5 mg HA. [1] Match this formulation to the locally supplied label and instructions. Manufacturer lists PN and a pack of two 2 mL syringes. [2] Confirm concentration, excipients and local pack; do not infer them from another REJURAN variant. Purpose / strength : A collagen-stimulation approach studied for skin quality. [1] A PN formulation with a manufacturer-listed purpose of temporary facial-wrinkle improvement. [2] Session protocol : A research protocol is not a universal treatment schedule. The treating clinician must confirm sessions, spacing, review points and maintenance for the exact product. Downtime : Skin injections can cause redness, tenderness, swelling or bruising. Recovery varies; neither is guaranteed to be downtime-free. [7] Obtain a procedure-specific recovery estimate. Skin concerns to discuss : Fine lines or uneven texture when a clinician considers a biostimulator appropriate. Fine lines or overall skin quality when a clinician considers a PN product appropriate. Limits : Mechanistic rationale and preliminary findings do not establish superiority over REJURAN. PN research does not establish that every REJURAN formulation treats every skin concern. Storage / shelf life : Storage temperature, shelf life and handling after preparation from the exact manufacturer's instructions and batch label. Manufacturer page specifies 1–30°C, protected from light. [2] Confirm local instructions, expiry and storage history; do not infer a shelf life. Pakistan availability / price : Current stock, supply route, applicable DRAP status and clinic treatment price have not been confirmed for either product. A listing or overseas authorization is not evidence of local authorization. Concern-based discussion prompts are editorial guidance, not a list of approved indications. The local label and clinician assessment take priority. 02 / From ingredient to decision How do they work, and what does the evidence show? A plausible mechanism is a starting point, not a forecast. Product identity, clinical evidence and an individual assessment all matter before a treatment plan makes sense. A decision process, not an injection protocol. Juvelook: rationale versus certainty A preliminary study of Juvelook's PDLLA–HA formulation investigated skin rejuvenation and reported tissue findings consistent with collagen stimulation. Its small, uncontrolled design and added treatment materials limit what can be concluded about Juvelook alone or comparisons with other products. [1] PN: read the comparator carefully A randomised split-face study compared a PN filler with non-crosslinked HA around the eyes. Results differed by outcome, and some overall improvement scores were not significantly different. It was not a Juvelook-versus-REJURAN trial. [6] Evidence boundary: the selected sources do not establish a head-to-head winner. Results from another ingredient, formulation, body area or animal model cannot be assumed to apply to your proposed treatment. 03 / Start with your concern Which should you choose for your skin concern? Choose the clinical question before choosing a brand. These “best for discussion” cards help you prepare for a consultation; they do not select a treatment for you. Texture / fine lines Ask about the evidence for your goal Discuss why a clinician might consider PDLLA–HA or PN for the particular area. Ask what improvement is realistic and how it will be assessed; no universal winner follows from the ingredient list. Acne scars / visible pores Get the concern assessed first Scar type and the cause of uneven texture matter. Ask whether either injectable has relevant evidence, or whether a different treatment would better address the concern. Dryness / sensitivity / redness Ask whether an injectable is appropriate at all These concerns can have different causes. A discussion of skincare, diagnosis and alternatives may be more useful than selecting a booster from a marketing description. Active inflammation or infection needs assessment before injections. [7] Editorial mechanism scale only. Positions are symbolic categories, not differences in effect size, safety, evidence strength or duration. Neither endpoint is “better”. 04 / Before you book What safety checks matter in Pakistan? Verify both the product and the person treating you. Keep a copy of the treatment record and know how to contact the clinic if a concern develops. Registration: ask for documentation for the exact device and importer, then check the applicable status with DRAP . Local authorization remains ; an overseas listing does not settle it. [8] Batch and expiry: ask to see the sealed pack, batch identifier, expiry and matching treatment record. A brand logo alone cannot authenticate a unit. Source and storage: request supplier traceability and confirmation that transport and storage followed the exact instructions. Clarify how the clinic handles any prepared product. Doctor qualification: check the clinician's licence and registered qualifications through the PM&DC practitioners register . Ask about relevant procedure training and complication management. [9] Your medical history: disclose allergies, including fish allergy when discussing salmon-derived PN, previous injections, medicines, pregnancy or breastfeeding, and active skin problems. The clinician should check product-specific contraindications. [3] [7] Know the escalation plan. Injection risks include infection, persistent lumps and serious complications if material enters a blood vessel. Unusual severe pain, skin colour change or vision symptoms during or after treatment need immediate medical attention. These are general injectable safety principles, not a comparison of the two products' event rates. [7] 05 / Questions patients ask What else should you know before deciding? Is Juvelook better than Rejuran? The sources reviewed here do not establish that one is better overall. Ask your doctor to connect your specific concern to the evidence for the exact formulation, and to explain alternatives. Are Rejuran, PN and PDRN the same thing? Rejuran is a brand, while PN and PDRN describe DNA-derived materials used in different formulations. Do not assume a PN injectable, a PDRN product and a topical product have interchangeable uses or evidence. Which is better for acne scars or visible pores? This comparison does not establish a winner for either concern. A dermatologist should first assess the scar type or cause of uneven texture, then explain whether an injectable or another approach is appropriate. How many sessions will I need, and how long do results last? There is no universal schedule or duration that applies to every formulation, treatment area and patient. Ask for a written plan with review points, likely maintenance and the evidence supporting those expectations. Is there downtime after Juvelook or Rejuran? Temporary redness, swelling, tenderness or bruising can follow skin injections, so neither should be presented as downtime-free. Your doctor should discuss recovery for the intended procedure and explain when symptoms need urgent attention. What do Juvelook and Rejuran cost in Pakistan? A current, comparable treatment price has not been verified for either product. Request an itemised clinic quote covering the exact formulation, amount used, consultation, follow-up and any proposed maintenance. FAQ evidence context: Juvelook study , variant distinction , PN trial and injectable safety . A clearer next step Need product information before your consultation? Contact Renz Medical with the exact product name to ask about available documentation and current supply information. Take those details to a qualified doctor to discuss suitability. Ask Renz Medical about product details → This is a product enquiry, not a treatment booking or a confirmation of stock. Do not purchase injectable products for self-administration. What related comparisons could you read next? Internal link slots for the publisher. Create or confirm each destination before turning these into links. Rejuran vs Profhilo: ingredients and evidence Suggested slot: /blog/rejuran-vs-profhilo Juvelook vs Profhilo: different approaches to skin quality Suggested slot: /blog/juvelook-vs-profhilo PN vs PDRN: what the ingredient names mean Suggested slot: /blog/pn-vs-pdrn Explore the Renz Medical Journal or professional clinical catalog for further product information. What sources support this comparison? Manufacturer information establishes identity and labelled product details; it does not independently prove superiority. Study findings are limited to their methods and populations. Sources checked 5 October 2026. Seo and colleagues: preliminary study of PDLLA with non-crosslinked HA . Journal of Cosmetic Dermatology, 2024; first published online 2023.Juvelook composition, collagen rationale and study limitations. No head-to-head REJURAN comparison. PharmaResearch: REJURAN injectable product information (Chinese-language manufacturer page).PN, two 2 mL syringes, stated purpose and storage; plain-English summary of the listed fields. PharmaResearch: REJURAN Australian launch announcement , 17 August 2023.Manufacturer identity and salmon-derived PN. Overseas authorization does not establish Pakistan status. PharmaResearch: separately named REJURAN Skin Booster .Used to distinguish the c-PDRN/HA/amino-acid formulation from the PN injectable. VAIM USA: Juvelook Skincare Serum .US topical-use labelling; not an injectable product endorsement. Lee and colleagues: randomised PN-versus-HA periocular trial . Journal of Dermatological Treatment, 2022; online 2020.Human PN evidence, with a different comparator and a specific treatment area. US FDA: dermal filler risks and patient information .General injection safety context; not evidence of FDA approval for either product compared here. DRAP: official e-services portal .Medical-device and verification service entry points; no product-specific registration has been confirmed. Pakistan Medical & Dental Council: practitioners register .Check licence validity and registered qualifications. Juvelook lower-eyelid study: product identity reference , 2025.VAIM and Korean product identity only; not a recommendation for under-eye treatment. Vietnam medical-device portal: REJURAN product advertising document (PDF).Manufacturer and country-of-origin corroboration; not Pakistan authorization. Medical disclaimer: this article provides general education, not a diagnosis, prescription or personalised treatment recommendation. Outcomes and risks vary. Consult a suitably qualified doctor before any procedure. The medical-review line is a placeholder until a named clinician has reviewed and approved the final text. What related long-tail searches could this guide support? Editorial keyword suggestions, not measured search-volume claims: Juvelook vs Rejuran for fine lines in Pakistan Juvelook vs Rejuran downtime and side effects PDLLA vs polynucleotide skin boosters explained Juvelook vs Rejuran for acne scars and pores how to check authentic Rejuran and Juvelook in Pakistan Keep this in mind The label is the starting point. Product variant, evidence, local documentation and your doctor's assessment belong in the same conversation. Different ingredients do not automatically mean better results. Compare the facts ↗ Check before you book ↗ Read the sources ↗

WhatsApp us